Literature DB >> 25694242

Krüppel-like factor 1 mutations and expression of hemoglobins F and A2 in homozygous hemoglobin E syndrome.

Wanicha Tepakhan1, Supawadee Yamsri, Goonnapa Fucharoen, Kanokwan Sanchaisuriya, Supan Fucharoen.   

Abstract

The basis for variability of hemoglobin (Hb) F in homozygous Hb E disease is not well understood. We have examined multiple mutations of the Krüppel-like factor 1 (KLF1) gene; an erythroid specific transcription factor and determined their associations with Hbs F and A2 expression in homozygous Hb E. Four KLF1 mutations including G176AfsX179, T334R, R238H, and -154 (C-T) were screened using specific PCR assays on 461 subjects with homozygous Hb E and 100 normal controls. None of these four mutations were observed in 100 normal controls. Among 461 subjects with homozygous Hb E, 306 had high (≥5 %) and 155 had low (<5 %) Hb F. DNA analysis identified the KLF1 mutations in 35 cases of the former group with high Hb F, including the G176AfsX179 mutation (17/306 = 5.6 %), T334R mutation (9/306 = 2.9 %), -154 (C-T) mutation (7/306 = 2.3 %), and R328H mutation (2/306 = 0.7 %). Only two subjects in the latter group with low Hb F carried the G176AfsX179 and -154 (C-T) mutations. Significant higher Hb A2 level was observed in those of homozygous Hb E with the G176AfsX179 mutation as compared to those without KLF1 mutations. These results indicate that KLF1 is among the genetic factors associated with increased Hbs F and A2, and in combination with other factors could explain the variabilities of these Hb expression in Hb E syndrome.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25694242     DOI: 10.1007/s00277-015-2335-x

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  5 in total

1.  Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β0-thalassemia/HbE disease.

Authors:  Pinyaphat Khamphikham; Orapan Sripichai; Thongperm Munkongdee; Suthat Fucharoen; Sissades Tongsima; Duncan R Smith
Journal:  Int J Hematol       Date:  2017-10-24       Impact factor: 2.490

2.  Molecular Analysis of Non-Transfusion Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia Disease without α-Thalassemia.

Authors:  Paramee Phanrahan; Supawadee Yamsri; Nattiya Teawtrakul; Goonnapa Fucharoen; Kanokwan Sanchaisuriya; Supan Fucharoen
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-07-01       Impact factor: 2.576

3.  Thalassemia and erythroid transcription factor KLF1 mutations associated with borderline hemoglobin A2 in the Thai population.

Authors:  Hataichanok Srivorakun; Wachiraporn Thawinan; Goonnapa Fucharoen; Kanokwan Sanchaisuriya; Supan Fucharoen
Journal:  Arch Med Sci       Date:  2020-08-11       Impact factor: 3.318

Review 4.  Krüppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants.

Authors:  Andrew Perkins; Xiangmin Xu; Douglas R Higgs; George P Patrinos; Lionel Arnaud; James J Bieker; Sjaak Philipsen
Journal:  Blood       Date:  2016-02-22       Impact factor: 22.113

5.  Haemoglobin switching modulator SNPs rs5006884 is associated with increased HbA2 in β-thalassaemia carriers.

Authors:  Cyril Cyrus; Chittibabu Vatte; Shahanas Chathoth; Abdul Azeez Sayed; J Francis Borgio; Mohammed Abdullah Alrubaish; Rawan Alfalah; Jana Alsaikhan; Amein K Al Ali
Journal:  Arch Med Sci       Date:  2019-07-18       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.